Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
| Species | Human |
| Cat.No | ABC-TC4341 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Mononuclear Cell |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Skin Cancer |
| Storage | Liquid Nitrogen |
| Product Type | Diseased Human Peripheral Blood Mononuclear Cells |
Human Skin Cancer Peripheral Blood Mononuclear Cells are a mixed population of immune cells isolated from the peripheral blood patients with skin cancer, including lymphocytes (T cells, B cells, NK cells) and monocytes. Morphologically, PBMCs are typically round or oval in shape. PBMCs are mainly involved in tumor immune surveillance and immune escape regulation in skin cancer. Among them, CD8+ T cells directly kill cancer cells by recognizing tumor antigens, while regulatory T cells (Treg) may inhibit anti-tumor immune responses and facilitate tumor progression. Monocytes may differentiate into tumor-associated macrophages (TAMs), contributing to the modulation of the tumor microenvironment.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human Skin Cancer Peripheral Blood Mononuclear Cells can be used to investigate the tumor antigen-specific killing function of CD8+ T cells, the immunosuppressive mechanism of regulatory T cells (Tregs), and the differentiation process of monocytes into tumor-associated macrophages (TAMs). These cells are also useful for identifying biomarkers related to disease progression or treatment response.